Kestra Medical Technologies (KMTS) Net Income towards Common Stockholders (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Net Income towards Common Stockholders data on file, last reported at -$38.8 million in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 29.83% year-over-year to -$38.8 million in Q2 2026; TTM through Apr 2026 was -$131.6 million, a 4.34% decrease from a year earlier, with the FY2026 full-year figure at -$131.6 million, down 4.34% from the prior year.
• Net Income towards Common Stockholders for Q2 2026 stood at -$38.8 million, down from -$34.2 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for KMTS reached as high as -$22.3 million in Q3 2024 and fell as low as -$55.3 million in Q2 2025.
• Historically, Net Income towards Common Stockholders has averaged -$30.5 million across 3 years, with a median of -$25.3 million in 2025.
• Across the five-year window, Net Income towards Common Stockholders tumbled 127.96% in 2025 and rose 29.83% in 2026, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$23.7 million in 2024, then slumped by 38.39% to -$32.8 million in 2025, then dropped by 18.45% to -$38.8 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$38.8 million in Q2 2026, -$34.2 million in Q1 2026, and -$32.8 million in Q4 2025.